![Frank Zavrl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Zavrl
Directeur/Bestuurslid bij
CERVOMED INC.
Vermogen: 1 M $ op 30-06-2026
Profiel
Frank E.
Zavrl currently works at CervoMed, Inc., as Independent Director from 2023.
Mr. Zavrl also formerly worked at Puma Biotechnology, Inc., as Independent Director from 2015 to 2020, EIP Pharma, Inc., as Non-Executive Director from 2018 to 2023, EIP Pharma LLC, as Director from 2017 to 2018, Adage Capital Management LP, as Equity Analyst, Zurich Scudder Investments, Inc., as Analyst from 1998 to 1999, and Merlin Biomed Group LLC, as Portfolio Manager from 1999 to 2002.
Mr. Zavrl received his undergraduate degree from the University of California, Berkeley and Masters Business Admin degree from Tuck School of Business at Dartmouth.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CERVOMED INC. 2,61% | 08-06-2026 | 353.009 ( 2,61% ) | 1 M $ | 30-06-2026 |
Actieve functies van Frank Zavrl
| Bedrijven | Functie | Begin |
|---|---|---|
| CERVOMED INC. | Directeur/Bestuurslid | 16-08-2023 |
Eerdere bekende functies van Frank Zavrl
| Bedrijven | Functie | Einde |
|---|---|---|
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Directeur/Bestuurslid | 01-08-2023 |
| PUMA BIOTECHNOLOGY, INC. | Directeur/Bestuurslid | 06-07-2020 |
EIP Pharma LLC | Directeur/Bestuurslid | 01-03-2018 |
Merlin Biomed Group LLC
 Merlin Biomed Group LLC Investment ManagersFinance Alternative investment manager | Corporate Officer/Principal | 01-01-2002 |
Zurich Scudder Investments, Inc.
 Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services | Corporate Officer/Principal | 01-01-1999 |
Opleiding van Frank Zavrl
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Adage Capital Management LP
 Adage Capital Management LP Investment ManagersFinance Adage manages ACP primarily through industry-specific portfolios that are managed by analyst/portfolio manager teams or individuals. The ACP aims to provide investors with compound annual long-term returns that outperform the returns of the S&P 500 Index. Their analysts focus on adding value by stock selection based on intra-industry fundamental analysis. In addition to taking long positions, the firm uses leverage, sells securities short, and invests in derivatives, US and non-US equities and private securities. | Finance |
Zurich Scudder Investments, Inc.
Zurich Scudder Investments, Inc. Regional BanksFinance Provides investment management services | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merlin Biomed Group LLC
Merlin Biomed Group LLC Investment ManagersFinance Alternative investment manager | Finance |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
EIP Pharma LLC | |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
Kies MarketScreener 
